![Damien McDevitt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Damien McDevitt
Chief Executive Officer at
ASPEN NEUROSCIENCE, INC.
Net worth: 8 M $ as of 30/09/2026
Profile
Dr. Damien McDevitt is a President, Chief Executive Officer & Director at Aspen Neuroscience, Inc. He is on the Board of Directors at Aspen Neuroscience, Inc. Dr. McDevitt was previously employed as a Chief Executive Officer & Director by Akcea Therapeutics, Inc., a Chief Business Officer by Ionis Pharmaceuticals, Inc., a Senior Vice President-Corporate Development by ACADIA Pharmaceuticals, Inc., and a Vice President by GlaxoSmithKline LLC.
He received his undergraduate degree from Trinity College Dublin and a doctorate degree from Trinity College Dublin.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/10/2026 | 561,648 ( 2.85% ) | 8 M $ | 30/09/2026 |
Damien McDevitt active positions
| Companies | Position | Start |
|---|---|---|
| ASPEN NEUROSCIENCE, INC. | Chief Executive Officer | 25/01/2021 |
Former positions of Damien McDevitt
| Companies | Position | End |
|---|---|---|
| AKCEA THERAPEUTICS, INC. | Chief Executive Officer | 01/01/2020 |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/09/2019 |
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/06/2018 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | 01/11/2017 |
Education of Damien McDevitt
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
82
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Trinity College Dublin
 Trinity College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Akcea Therapeutics, Inc.
 Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for cardiometabolic lipid disorders | Health Technology |
Aspen Neuroscience, Inc.
 Aspen Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage regenerative medicine biotechnology company and develops autologous induced-pluripotent stem cell | Health Technology |
- Stock Market
- Insiders
- Damien McDevitt
